Thousands with Multiple Sclerosis to Gain Access to New NHS Treatment Friday, January 2, 2026 ms multiplesclerosis natalizumab nhs rrms treatment autoimmune dmt neurology healthcare Thousands of people in England living with multiple sclerosis (MS), specifically the relapsing-remitting form (RRMS), are set to benefit from a newly recommended treatment available on the NHS. The National Institute for … Read More
New NHS Treatment Offers Hope to Thousands with Relapsing-Remitting MS Friday, January 2, 2026 multiple sclerosis ms relapsing-remitting natalizumab nhs treatment autoimmune tysabri tyruko nice Thousands of people in England living with relapsing-remitting multiple sclerosis (RRMS) are set to benefit from a newly approved treatment on the NHS. The National Institute for Health and Care Excellence (NICE) has … Read More
NHS Issues Important Guidance for Four Groups on Beclometasone Inhalers Used in Asthma Treatment Wednesday, December 31, 2025 asthma inhalers beclometasone respiratory copd steroids nhs treatment prevention medication Beclometasone inhalers are a commonly prescribed treatment for asthma and certain respiratory conditions, functioning primarily as preventer medications to reduce airway inflammation and control symptoms. The NHS has issued … Read More
NHS Dentistry Overhaul to Save Patients Up to £225 and Improve Access from April 2026 Tuesday, December 16, 2025 nhs dentistry reforms treatment patients dentalcare prevention access healthcosts oralhealth The NHS dentistry service across England is set for a significant transformation aimed at prioritising urgent and complex cases while saving patients money through customised treatment plans. Announced by the government … Read More
NHS Highlights Key Prostate Cancer Symptoms Following Cliff Richard’s Diagnosis Monday, December 15, 2025 prostate cancer nhs screening symptoms diagnosis cliffrichard treatment awareness genetics Prostate cancer can often be detected early through awareness of key symptoms, enabling timely treatment. This message gained renewed attention after Sir Cliff Richard disclosed his prostate cancer diagnosis and treatment … Read More
Alzheimer’s Drug Lecanemab Can Slow Disease Progression by Over Eight Years, Says New Research Thursday, December 4, 2025 alzheimer’s lecanemab nhs dementia research amyloid treatment cost diagnosis alzheimer New research presented at the Clinical Trials in Alzheimer’s Disease (CTAD) conference in San Diego suggests that the Alzheimer’s drug lecanemab, licensed in the UK but not available on the NHS, can slow disease progression … Read More